Related Experiment Video
Updated: Jun 13, 2025

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Bronchopulmonary Dysplasia with Pulmonary Hypertension Associates with Loss of Semaphorin Signaling and Functional
Insights
Infant lung injury can cause bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH). This study reveals aberrant capillary cells and semaphorin signaling deficits in BPD lungs, linking BPD and alveolar capillary dysplasia.
Area of Science:
- Neonatal respiratory medicine
- Molecular biology
- Developmental biology
Background:
- Infant lung injury can lead to bronchopulmonary dysplasia (BPD), a condition associated with structural and functional respiratory deficits.
- Severe BPD can progress to pulmonary hypertension (PH), impacting infant health outcomes.
- Understanding the cellular and molecular mechanisms driving BPD progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the cellular and molecular dynamics of evolving bronchopulmonary dysplasia (BPD) in preterm infants.
- To compare lung tissue from infants with early-stage BPD and BPD with pulmonary hypertension (PH) to that of term infants.
- To identify key molecular pathways and cell states involved in BPD pathogenesis.
Main Methods:
- Single-cell RNA sequencing was performed on lung tissue samples from preterm infants with BPD/BPD+PH and term infants.
- Endothelial cell states were analyzed to identify aberrant cell populations.
- Predictive signaling pathway analysis was used to identify molecular deficits.
- A murine BPD model and human samples with alveolar capillary dysplasia (ACDMPV) were used for validation.
Main Results:
- A unique aberrant capillary cell-state, characterized by *ANKRD1* expression, was identified in infants with BPD and PH.
- Deficits in the semaphorin guidance-cue signaling pathway were observed in the alveolar parenchyma of infants with BPD/BPD+PH.
- Decreased expression of the pro-angiogenic transcription factor *FOXF1* was found in BPD/BPD+PH lung samples.
- Loss of semaphorin signaling was replicated in a murine BPD model and in human ACDMPV cases.
Conclusions:
- Aberrant capillary cell states and semaphorin signaling pathway deficits are key features of BPD in preterm infants.
- Semaphorin signaling plays a critical role in normal lung development and may be mechanistically linked to BPD and ACDMPV.
- These findings provide insights into the developmental programs underlying BPD and ACDMPV, suggesting potential therapeutic targets.
Abstract:
Lung injury in preterm infants leads to structural and functional respiratory deficits, with a risk for bronchopulmonary dysplasia (BPD) that in its most severe form is accompanied by pulmonary hypertension (PH). To examine cellular and molecular dynamics driving evolving BPD in humans, we performed single-cell RNA sequencing of preterm infant lungs in early stages of BPD and BPD+PH compared to term infants. Analysis of the endothelium revealed a unique aberrant capillary cell-state primarily in BPD+PH marked by ANKRD1 expression. Predictive signaling analysis identified deficits in the semaphorin guidance-cue signaling pathway and decreased expression of pro-angiogenic transcription factor FOXF1 within the alveolar parenchyma in neonatal lung samples with BPD/BPD+PH. Loss of semaphorin signaling was replicated in a murine BPD model and in humans with alveolar capillary dysplasia (ACDMPV), suggesting a mechanistic link between the developmental programs underlying BPD and ACDMPV and a critical role for semaphorin signaling in normal lung development.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Hedgehog Signaling Pathway
Breathing

